Treatment of 40 Diabetic Peripheral Neuropathy Patients with Moxibustion plus Mecobalamin

Objective To evaluate the clinical efficacy of moxibustion plus Mecobalamin in treating diabetic peripheral neuropathy.Methods Eighty patients exactly diagnosed as having diabetic peripheral neuropathy were allocated at a ratio of one to one to combination and control groups.On the basis of the same basic treatment,the combination group was treated with moxibustion plus Mecobalamin and the control group,with simple Mecobalamin.Treatment lasted 3 months.Nerve conduction velocity and symptom severity were compared between pretreatment and posttreatment.Results Nerve conduction velocity improved in both combination and control groups and more obviously in the combination group.The marked efficacy rate,efficacy rate and inefficacy rate were 52.5%,(32.5%) and 15.0%,respectively,in the combination group and 35.0%,27.5% and 37.5%,respectively,in the control group.There was a statistically significant difference between the two groups(P0.01 or P0.05).Conclusion Based on a basic treatment,moxibustion plus Mecobalamin is superior to simple Mecobalamin in treating diabetic peripheral neuropathy.